"The National Blood Authority’s 2016-2017annual reportindicates Australian imports of immunoglobulin, a plasma component, provide 44% of domestic demand. This costs A$120 million while the remaining 56% comes from domestic supply costing A$413 million.

"This implies the domestic supply of immunoglobulin costs over three times more per unit than what is imported, despite domestic donors not being compensated."